Journal Publications
5.1
Development and validation of an LC-MSMS method for simultaneous determination of three organic azido impurities in tetrazole-containing sartans
5.2
An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals
5.3
Current status and prospects of development of analytical methods for determining nitrosamine and
N
-nitroso impurities in pharmaceuticals
5.4
Development of a Sensitive Headspace Gas Chromatography−Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients
5.5
An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals
5.6
Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Simple Analysis of Sumatriptan and its Application in Bioequivalence Study
5.7
A simple and sensitive HPLC-fluorescence method for the determination of moxifloxacin in human plasma and its application in a pharmacokinetic study
5.8
Determination of Levocetirizine in Human Plasma by LC–MS-MS: Validation and Application in a Pharmacokinetic Study
5.9
Development of a Simplified Heart-Cutting Two-Dimensional Liquid Chromatography Method for Green Analysis of Four Polyphenols in
Aerides
Plants